FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression

FEBS Letters

Volumn 586, Issue 19, 2012, Pages 3044-3050

  Wang, Tao ^a,b   Pei, Xuelian ^a,b   Zhan, Jun ^a,b   Hu, Jinxia ^a,b   Yu, Yu ^a,b   Zhang, Hongquan ^a,b  

^a Department of Biochemistry and Molecular BiologyCancer Hospital of Peking University   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Adherens junction; E cadherin; FRMD5; p120 Catenin; Tumor suppressive protein

Indexed keywords

CATENIN; CYTOSKELETON PROTEIN; FERM DOMAIN CONTAINING PROTEIN 5; PROTEIN P120; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL JUNCTION; CELL MIGRATION; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; CATENINS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HCT116 CELLS; HELA CELLS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PHYLOGENY; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS;

EID: 84866612504     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.07.019     Document Type: Article

References (23)

1. Z. An, K. Dobra, J.G. Lock, S. Stromblad, A. Hjerpe, and H. Zhang Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration Int. J. Cancer 127 2010 1999 2008
2. U. Tepass FERM proteins in animal morphogenesis Curr. Opin. Genet. Dev. 19 2009 357 367
3. A.J. Baines A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function BMC Genomics 7 2006 85
4. J. Conboy Molecular cloning and characterization of the gene coding for red cell membrane skeletal protein 4.1 Biorheology 24 1987 673 687
5. V.A. Robb, W. Li, P. Gascard, A. Perry, N. Mohandas, and D.H. Gutmann Identification of a third protein 4.1 tumor suppressor, protein 4.1R, in meningioma pathogenesis Neurobiol. Dis. 13 2003 191 202
6. S. Huang Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas Eur. J. Clin. Invest. 31 2001 907 914
7. V. Rajaram, D.H. Gutmann, S.K. Prasad, D.B. Mansur, and A. Perry Alterations of protein 4.1 family members in ependymomas: a study of 84 cases Mod. Pathol. 18 2005 991 997
8. D. Haase, M. Meister, T. Muley, J. Hess, S. Teurich, P. Schnabel, B. Hartenstein, and P. Angel FRMD3, a novel putative tumour suppressor in NSCLC Oncogene 26 2007 4464 4468
9. Y.K. Tran, O. Bogler, K.M. Gorse, I. Wieland, M.R. Green, and I.F. Newsham A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer Cancer Res. 59 1999 35 43
10. D.H. Gutmann Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas Hum. Mol. Genet. 9 2000 1495 1500
11. A.L. Charboneau, V. Singh, T. Yu, and I.F. Newsham Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells Int. J. Cancer 100 2002 181 188
12. D. Yamada Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma Int. J. Cancer 118 2006 916 923
13. S.Y. Wong Protein 4.1B suppresses prostate cancer progression and metastasis Proc. Natl. Acad. Sci. USA 104 2007 12784 12789
14. D.H. Gutmann Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas Human molecular genetics 9 2000 1495
15. M. Hirano, S. Hashimoto, S. Yonemura, H. Sabe, and S. Aizawa EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial-mesenchymal transition J. Cell Biol. 182 2008 1217 1230
16. M. Brazdova Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences Nucleic Acids Res. 37 2009 1486 1500
17. D.C. Seo Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells Mol. Cancer 6 2007 75
18. J. Ren, L. Wen, X. Gao, C. Jin, Y. Xue, and X. Yao DOG 1.0: illustrator of protein domain structures Cell Res. 19 2009 271 273
19. V. Ohanian, L.C. Wolfe, K.M. John, J.C. Pinder, S.E. Lux, and W.B. Gratzer Analysis of the ternary interaction of the red cell membrane skeletal proteins spectrin, actin, and 4.1 Biochemistry 23 1984 4416 4420
20. R.C. Ireton A novel role for p120 catenin in E-cadherin function J. Cell Biol. 159 2002 465 476
21. M.J. Wheelock, Y. Shintani, M. Maeda, Y. Fukumoto, and K.R. Johnson Cadherin switching J. Cell Sci. 121 2008 727 735
22. C.X. Sun, V.A. Robb, and D.H. Gutmann Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation J. Cell Sci. 115 2002 3991 4000
23. A.B. Reynolds, J. Daniel, P.D. McCrea, M.J. Wheelock, J. Wu, and Z. Zhang Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes Mol. Cell Biol. 14 1994 8333 8342